This review highlights the methodological challenges in conducting cost-effectiveness analyses for anaesthetic drugs.
Challenges in evaluating anaesthetic drug costs versus benefits warrant caution in practice; leaves open improved methodologies for future analyses.
Measuring the direct drug costs of an anaesthetic is relatively easy, but assessing increased expenditure in relation to clinical benefits and indirect costs is not. This review examines a number of papers that have attempted just such a task and tries to illustrate some of the difficulties inherent in this important area of cost-effective analyses.
No takes yet. Share an insight, caveat, or question.
Allan et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: